Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Welander

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
What do CA 125 and other antigens tell us about ovarian cancer biology?C E Welander
Cancer|February 1, 1987
Use of interferon in the treatment of ovarian cancer as a single agent and in combination with cytotoxic drugsC E Welander
Investigational New Drugs|January 1, 1987
Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugsC E Welander
Cancer|February 1, 1987
Interferons in the treatment of multiple myelomaM R Cooper, C E Welander
Cancer Research|March 1, 1986
Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assayT Saito, M E Berens, C E Welander
Cancer Chemotherapy and Pharmacology|January 1, 1987
Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assayT Saito, M E Berens, C E Welander
American Journal of Obstetrics and Gynecology|August 1, 1991
Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancerC E Welander, H D Homesley, R J Barrett
American Journal of Obstetrics and Gynecology|September 15, 1983
In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?C E Welander, H D Homesley, V W Jobson
American Journal of Obstetrics and Gynecology|September 1, 1992
Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal massesF Nezhat, C Nezhat, C E Welander, et al.
Gynecologic Oncology|September 19, 1998
Advanced ovarian carcinoma presenting with a cerebrovascular accidentM I Shamonki, R C Squatrito, C E Welander
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
What do CA 125 and other antigens tell us about ovarian cancer biology?C E Welander
Cancer|February 1, 1987
Use of interferon in the treatment of ovarian cancer as a single agent and in combination with cytotoxic drugsC E Welander
Investigational New Drugs|January 1, 1987
Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugsC E Welander
Cancer|February 1, 1987
Interferons in the treatment of multiple myelomaM R Cooper, C E Welander
Cancer Research|March 1, 1986
Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assayT Saito, M E Berens, C E Welander
Cancer Chemotherapy and Pharmacology|January 1, 1987
Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assayT Saito, M E Berens, C E Welander
American Journal of Obstetrics and Gynecology|August 1, 1991
Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancerC E Welander, H D Homesley, R J Barrett
American Journal of Obstetrics and Gynecology|September 15, 1983
In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?C E Welander, H D Homesley, V W Jobson
American Journal of Obstetrics and Gynecology|September 1, 1992
Four ovarian cancers diagnosed during laparoscopic management of 1011 women with adnexal massesF Nezhat, C Nezhat, C E Welander, et al.
Gynecologic Oncology|September 19, 1998
Advanced ovarian carcinoma presenting with a cerebrovascular accidentM I Shamonki, R C Squatrito, C E Welander
Pageof 4